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Therapeutic hypothermia in middle-income settings: Where to now? 
Worldwide, deaths related to complications around the time of birth (intrapartum-related deaths), 
are the third leading cause of under 5-mortality.1 Globally, each year, an estimated 1.15 million 
infants develop NE with around a quarter of survivors affected by long-term neurodisability.1 The 
majority of this burden falling on the poorest of countries.  
In this issue, Kali et al. describe the early outcomes of infants with hypoxic-ischaemic 
encephalopathy (HIE) after introduction of therapeutic hypothermia (TH) to their neonatal service in 
the Western Cape province of South Africa.2 Therapeutic whole body cooling to a core temperature 
of 33.5°C for 72 hours, is standard of care in many high income countries (HICs) with evidence of 
increased disability-free survival and improved cognitive outcomes at early school age. However, 
evidence from low- and middle-income settings is limited, with the only systematic review of TH in 
this setting (567 infants, 7 studies) failing to show a significant reduction in neonatal mortality.3  
 
One of the great strengths of the study by Kali et al. is that the outcomes that they report are from a 
‘real life’ cohort from a middle-income setting.2 In doing so, they have effectively highlighted many 
of the challenges faced in translating evidence and protocols from HIC studies to a mid-resource 
setting, where important differences in population and care setting frequently exist.  Ideally, an RCT 
examining the effectiveness of TH would be conducted, however, a normothermic study arm is 
surely hard to justify in a setting where neonatal intensive care is available, and where the authors 
themselves have previously shown TH to be safe and feasible.4  
 
An important factor highlighted by this study is the differences in definition of HIE between different 
resource settings that may influence early outcomes. Definitions of HIE used in HIC cooling trials may 
be difficult to replicate where limitation or lack of diagnostic tools such as cord gas measurement 
and aEEG are less common. Whilst Kali et al. successfully met common cord/blood gas criteria, early 
aEEG, used to define ‘moderate/severe’ encephalopathy for inclusion in the Toby study, was clearly 
not always available, and difficulties around quality control are also highlighted. Perhaps as a result, 
around a third of infants receiving TH were ultimately defined as mildly encephalopathic and 
therefore would not meet current criteria for TH in HICs.  
 
Differing aetiology of HIE may also effect outcomes in different settings. High delivery rates, lower 
staff to patient ratios and delays in transfer time more common in lower resource settings are likely 
to affect the nature and timing of insult and may mean that the narrow therapeutic window for early 
intervention has passed. Different prevalence’s of important co-morbidities such as infection and 
hypoglycaemia may also affect outcome.  
 
What is clear is that more research from middle-income country settings is desperately needed if we 
are to facilitate our understanding of how TH protocols may be safely and effectively introduced in 
middle-income settings, so that in the future many more newborns can safely and effectively benefit 
from this life changing intervention. 
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